The current coronavirus (COVID-19) pandemic is an unprecedented public health emergency in the U.S. Even though medical professionals are working around the clock to conduct testing, the problem still remains to be a shortage of diagnostic kits. Aimed to improve the limited diagnostic capability and to fight against the COVID-19 public health crisis, the FDA issued several emergency policies since late February.